Elizabeth B Lamont

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to"
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, and the Cancer Research Center, University of Chicago, Chicago, IL, USA
    JAMA 290:98-104. 2003
  2. ncbi request reprint Chemotherapy in the management of squamous-cell carcinoma of the head and neck
    E B Lamont
    Section of Hematology Oncology, Cancer Research Center, University of Chicago, IL 60637, USA
    Lancet Oncol 2:261-9. 2001
  3. ncbi request reprint Physician factors in the timing of cancer patient referral to hospice palliative care
    Elizabeth B Lamont
    Sections of General Medicine and Hematology Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA
    Cancer 94:2733-7. 2002
  4. ncbi request reprint Favorable cardiac risk among elderly breast carcinoma survivors
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Cancer 98:2-10. 2003
  5. ncbi request reprint Low risk of hip fracture among elderly breast cancer survivors
    Elizabeth B Lamont
    Department of Medicine, The University of Chicago, Chicago, IL, USA
    Ann Epidemiol 13:698-703. 2003
  6. ncbi request reprint Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia
    Supriya K Gupta
    Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
    J Am Geriatr Soc 52:1681-7. 2004
  7. ncbi request reprint Is patient travel distance associated with survival on phase II clinical trials in oncology?
    Elizabeth B Lamont
    Department of Medicine and Cancer Research Center, The University of Chicago, Chicago, IL, USA
    J Natl Cancer Inst 95:1370-5. 2003
  8. ncbi request reprint Construct validity of medicare chemotherapy claims: the case of 5FU
    Elizabeth B Lamont
    Section of Hematology Oncology, University of Chicago, Illinois 60637, USA
    Med Care 40:201-11. 2002
  9. ncbi request reprint Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer
    Theodore J Iwashyna
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Clin Oncol 20:3992-8. 2002
  10. ncbi request reprint Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Cancer 106:923-30. 2006

Detail Information

Publications19

  1. ncbi request reprint Complexities in prognostication in advanced cancer: "to help them live their lives the way they want to"
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, and the Cancer Research Center, University of Chicago, Chicago, IL, USA
    JAMA 290:98-104. 2003
    ..Using the vignette of a real patient with advanced cancer who far outlived her physician's prognostic estimate, we discuss clinical issues related to the science of prognosis in advanced cancer and the art of its disclosure...
  2. ncbi request reprint Chemotherapy in the management of squamous-cell carcinoma of the head and neck
    E B Lamont
    Section of Hematology Oncology, Cancer Research Center, University of Chicago, IL 60637, USA
    Lancet Oncol 2:261-9. 2001
    ....
  3. ncbi request reprint Physician factors in the timing of cancer patient referral to hospice palliative care
    Elizabeth B Lamont
    Sections of General Medicine and Hematology Oncology, Department of Medicine and Cancer Research Center, University of Chicago, Chicago, Illinois, USA
    Cancer 94:2733-7. 2002
    ..In the current study, the authors attempted to determine whether the attributes of referring physicians were associated with the survival of terminally ill cancer patients in hospice...
  4. ncbi request reprint Favorable cardiac risk among elderly breast carcinoma survivors
    Elizabeth B Lamont
    Section of General Internal Medicine, Department of Medicine, The University of Chicago, Chicago, Illinois 60637, USA
    Cancer 98:2-10. 2003
    ..First, estrogens may be etiologic in the development of breast carcinoma and protective of CHD. Second, a common therapy for breast carcinoma (tamoxifen) may be associated with cardiac protection...
  5. ncbi request reprint Low risk of hip fracture among elderly breast cancer survivors
    Elizabeth B Lamont
    Department of Medicine, The University of Chicago, Chicago, IL, USA
    Ann Epidemiol 13:698-703. 2003
    ..Little prior work has evaluated whether women with breast cancer are at a decreased risk of osteoporotic fracture...
  6. ncbi request reprint Patterns of presentation, diagnosis, and treatment in older patients with colon cancer and comorbid dementia
    Supriya K Gupta
    Section of Hematology Oncology, University of Chicago, Chicago, Illinois 60637, USA
    J Am Geriatr Soc 52:1681-7. 2004
    ..To estimate patterns of colon cancer presentation, diagnosis, and treatment according to history of dementia using National Cancer Institute (NCI) Surveillance, Epidemiology, and End-Result (SEER) Medicare data...
  7. ncbi request reprint Is patient travel distance associated with survival on phase II clinical trials in oncology?
    Elizabeth B Lamont
    Department of Medicine and Cancer Research Center, The University of Chicago, Chicago, IL, USA
    J Natl Cancer Inst 95:1370-5. 2003
    ..We hypothesized that this phenomenon, often called "referral bias" or "distance bias," may also be evident in curative-intent cancer trials at specialized cancer centers...
  8. ncbi request reprint Construct validity of medicare chemotherapy claims: the case of 5FU
    Elizabeth B Lamont
    Section of Hematology Oncology, University of Chicago, Illinois 60637, USA
    Med Care 40:201-11. 2002
    ..The elderly are under represented in clinical trials of cancer therapy and the elderly who are enrolled may be unrepresentative...
  9. ncbi request reprint Effectiveness of adjuvant fluorouracil in clinical practice: a population-based cohort study of elderly patients with stage III colon cancer
    Theodore J Iwashyna
    Department of Medicine, Hospital of the University of Pennsylvania, Philadelphia, PA, USA
    J Clin Oncol 20:3992-8. 2002
    ..In this study, we ask the following: (1) What is the hazard of death associated with adjuvant 5-FU in the general population of elderly stage III colon cancer patients? (2) Does the hazard vary with patient age?..
  10. ncbi request reprint Are venous thromboembolic events associated with subsequent breast and colorectal carcinoma diagnoses in the elderly? A case-control study of Medicare beneficiaries
    Blase N Polite
    Section of Hematology Oncology, Department of Medicine, University of Chicago, IL 60637, USA
    Cancer 106:923-30. 2006
    ..Multiple epidemiologic studies have reported associations between venous thromboembolic events and subsequent cancer diagnoses, but the published results have not suggested clear cancer screening approaches...
  11. doi request reprint Understanding variation in primary prostate cancer treatment within the Veterans Health Administration
    Vinod E Nambudiri
    Department of Medicine, Brigham and Women s Hospital, Boston, Massachusetts 02115, USA
    Urology 79:537-45. 2012
    ..To examine the variation in prostate cancer treatment in the Veterans Health Administration (VHA)--a national, integrated delivery system. We also compared the care for older men in the VHA with that in fee-for-service Medicare...
  12. ncbi request reprint Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344)
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA, USA
    J Natl Cancer Inst 98:1335-8. 2006
    ....
  13. ncbi request reprint Patient time costs associated with cancer care
    K Robin Yabroff
    Health Services and Economics Branch, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 99:14-23. 2007
    ..In this study, we estimated patient time costs associated with cancer care in patients aged 65 years and older in the United States...
  14. pmc NSAIDs and colorectal cancer risk: do administrative data support a chemopreventive effect?
    Elizabeth B Lamont
    Massachusetts General Hospital Cancer Center, Boston, MA, USA
    J Gen Intern Med 22:1166-71. 2007
    ..We sought to estimate the effectiveness of NSAIDs in CRC prevention in the population of elderly Medicare beneficiaries, minimizing this selection bias...
  15. doi request reprint Measuring clinically significant chemotherapy-related toxicities using Medicare claims from Cancer and Leukemia Group B (CALGB) trial participants
    Elizabeth B Lamont
    Massachusetts General Hospital, Boston, Massachusetts, USA
    Med Care 46:303-8. 2008
    ..Because the elderly are underrepresented on clinical trials, physicians have few sources of information to estimate the risks (ie, toxicities) and benefits of chemotherapy administration to the elderly...
  16. doi request reprint Cost of care for elderly cancer patients in the United States
    K Robin Yabroff
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 100:630-41. 2008
    ..We estimated net costs of care for elderly cancer patients in the United States for the 18 most prevalent cancers and for all other tumor sites combined...
  17. pmc Evaluation of trends in the cost of initial cancer treatment
    Joan L Warren
    Health Services and Economics Branch Applied Research Program, Division of Cancer Control and Population Sciences, National Cancer Institute, Executive Plaza North, Rm 4005, 6130 Executive Blvd, MSC 7344, Bethesda, MD 20892 7344, USA
    J Natl Cancer Inst 100:888-97. 2008
    ..Despite reports of increases in the cost of cancer treatment, little is known about how costs of cancer treatment have changed over time and what services have contributed to the increases...
  18. ncbi request reprint Criterion validity of Medicare chemotherapy claims in Cancer and Leukemia Group B breast and lung cancer trial participants
    Elizabeth B Lamont
    Department of Medicine and Institute for Technology Assessment, Massachusetts General Hospital, Boston, MA 02114, USA
    J Natl Cancer Inst 97:1080-3. 2005
    ..Administrative Medicare claims data appear to be a valid source of information for chemotherapy administered to elderly Medicare beneficiaries with cancer...
  19. ncbi request reprint Cancer and leukemia group B cancer control and health outcomes committee: origins and accomplishments
    Electra D Paskett
    Comprehensive Cancer Center, Ohio State University, Columbus, Ohio, USA
    Clin Cancer Res 12:3601s-5s. 2006
    ..Cancer control research is growing and continues to gather momentum. This type of research is integral to providing quality care to patients and healthy populations...